Stem-cell-protecting drug could prevent the harmful side effects of radiation therapy
Thursday, September 6, 2012 - 12:30
in Health & Medicine
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study.